Document is current
Any future updates will be listed below
-
Authors
Chavez-Yenter, Daniel
Fetzer, Dominique
Egleston, Brian
Domchek, Susan
Fleisher, Linda
Wagner, Lynne I.
Wen, Kuang-Yi
Karpink, Kelsey
Gutstein, Lauren
Posen, Shelby
Selmani, Enida
McLeod, Briana
Anantharajah, Arravinth
Brown, Sarah
Cacioppo, Cara
Cappadocia, Jacqueline
Ebrahimzadeh, Jessica E.
Falcone, Dana
Howe, Sarah
Langer, Claire
McCarthy-Wood, Beth
Weinberg, Michelle
Bradbury, Angela R.
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG-18-192-CPHPS)
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 1 September 2025
First Online: 24 October 2025
Declarations
:
: The protocol for the study has been reviewed and approved by the University of Pennsylvania (Penn) IRB 832628. All participants signed informed consent forms to participate in the study.
: Not applicable.
: Dr. Bradbury receives partial research funding from Astrazeneca and Merck for other studies. The other authors declare no competing interests.
: A Data and Event Monitoring Committee (DEMC) is required for this study. The project is considered to have “minimal risk” to participants. The IRB and DEMC will be notified of any unanticipated events.
